Literature DB >> 8581557

Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.

J S Schneider1, A Pope-Coleman.   

Abstract

Five adult Macaca fascicularis monkeys were trained to perform tests of cognitive and motor functioning that included a complex visual pattern discrimination task, an object retrieval task, a test of task persistence, and a timed motor task. Once stable baseline performance was achieved, monkeys were administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at doses of 0.05 to 0.075 mg/kg, 2 to 3 times per week for a total of 24 weeks. Animals were assessed weekly for performance on the previously learned tasks. All monkeys developed performance deficits in a predictable pattern with behavioural and cognitive deficits (i.e. deficits in task persistence and the cognitive component of object retrieval) appearing in advance of measurable motor deficits. Deficits in visual pattern discrimination never appeared. These results show that specific cognitive dysfunction pre-dates motor dysfunction in a chronic, slowly progressing parkinson model in monkeys and support the contention that cognitive deficits in Parkinson's disease may precede the motor signs of the disorder and may not be caused by them.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581557     DOI: 10.1016/1055-8330(95)90014-4

Source DB:  PubMed          Journal:  Neurodegeneration        ISSN: 1055-8330


  19 in total

1.  Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates.

Authors:  Jay S Schneider; Emmanuel Decamp; Amy Jo Koser; Stephanie Fritz; Heather Gonczi; Tore Syversen; Tomás R Guilarte
Journal:  Brain Res       Date:  2006-09-15       Impact factor: 3.252

Review 2.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

Review 3.  Pathophysiology of dyskinesia and behavioral disorders in non-human primates: the role of serotonergic fibers.

Authors:  Véronique Sgambato; Léon Tremblay
Journal:  J Neural Transm (Vienna)       Date:  2018-03-03       Impact factor: 3.575

Review 4.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

Review 5.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

Review 6.  Non-human primate models of PD to test novel therapies.

Authors:  Marc Morissette; Thérèse Di Paolo
Journal:  J Neural Transm (Vienna)       Date:  2017-04-08       Impact factor: 3.575

Review 7.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

Review 8.  Manganese: recent advances in understanding its transport and neurotoxicity.

Authors:  Michael Aschner; Tomás R Guilarte; Jay S Schneider; Wei Zheng
Journal:  Toxicol Appl Pharmacol       Date:  2007-03-12       Impact factor: 4.219

9.  Dopaminergic denervation and spine loss in the striatum of MPTP-treated monkeys.

Authors:  Rosa M Villalba; Heyne Lee; Yoland Smith
Journal:  Exp Neurol       Date:  2008-10-11       Impact factor: 5.330

10.  Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model.

Authors:  E Decamp; J S Schneider
Journal:  Brain Res       Date:  2009-02-07       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.